Asthma and obesity have a considerable impact on public health and their prevalence has increased in recent years. Numerous studies have linked these disorders. Most prospective studies show that obesity is a risk factor for asthma and have found a positive correlation between baseline body mass index and the subsequent development of asthma. Furthermore, several studies suggest that whereas weight gain increases the risk of asthma, weight loss improves the course of the illness. Different factors could explain this association. Obesity is capable of reducing pulmonary compliance, lung volumes, and the diameter of peripheral respiratory airways as well as affecting the volume of blood in the lungs and the ventilation-perfusion relationship. Furthermore, the increase in the normal functioning of adipose tissue in obese subjects leads to a systemic proinfl ammatory state, which produces a rise in the serum concentrations of several cytokines, the soluble fractions of their receptors, and chemokines. Many of these mediators are synthesized and secreted by cells from adipose tissue and receive the generic name of adipokines, including IL-6, IL-10, eotaxin, tumor necrosis factor-α, transforming growth factors-ß1, C-reactive protein, leptin, and adiponectin. Finally, specifi c regions of the human genome related to both asthma and obesity have been identifi ed. Most studies point out that obesity is capable of increasing the prevalence and incidence of asthma, although this effect appears to be modest. The treatment of obese asthmatics must include a weight control program.
Introduction
Asthma and obesity have an enormous impact on public health. It has been estimated that up to 65% of the adult population of the United States is obese or overweight [1] , whilst in Spain about 15% of the population is obese and 39% is overweight, and these fi gures have increased progressively in recent years. Although bronchial asthma affects a smaller percentage of people, its prevalence has also increased since the 1960s. According to the Centers for Disease Control and Prevention [2] , the prevalence of asthma in North American children increased from 3.6% in 1980 to 5.8% in 2003.
Both asthma and allergic diseases are associated with a western lifestyle and their prevalence has increased in developed countries. This can be seen clearly from the rapid increase in the prevalence of asthma in children who have emigrated from developing to developed countries [3] and, more recently, the rapid rise in the prevalence of allergic diseases in the former East Germany shortly after German reunifi cation [4] . The factors in western lifestyles that have been considered responsible for this increased prevalence are greater exposure to allergens in the home and changes in contact with different microorganisms (the hygiene hypothesis).
In recent years, many studies [5] in developed countries have suggested a relationship between asthma and factors such as changes in diet and obesity. Although the exact nature of this association has not been fully elucidated, epidemiological data have led researchers to suggest that obesity precedes asthma, increases both its prevalence and severity, and may lessen the effi cacy of those drugs normally used in its treatment.
Epidemiological Observations

Cross-Sectional Studies
Several cross-sectional studies have found an increase in the prevalence of asthma among obese patients [5] . These studies include a high number of patients and have provided signifi cant epidemiological data on both disorders. However, given that the data on weight and height for the calculation of the body mass index (BMI) were self-reported, they may be inaccurate and biased and should therefore be interpreted with caution. Furthermore, in some studies [5] , asthma was diagnosed and classifi ed solely on the basis of a compatible clinical history or acceptance of a previous diagnosis. Finally, both asthma and obesity may be independently associated with other confounding factors such as sleep apnea or gastroesophageal refl ux disease, which were not excluded from many of these studies. However, when the studies partially or fully overcame these shortcomings, an association was found between elevated BMI and asthma [6] [7] [8] .
A further potential limitation of cross-sectional studies is the diffi culty in establishing causality: patients presenting with asthma may develop obesity for a variety of reasons, including inactivity or the side effects of systemic corticosteroids. Without control of these factors in a longitudinal study, it is diffi cult to establish whether asthma is the cause of obesity or the result.
Prospective Studies
In recent years, numerous prospective studies [9-13] including a high number of patients (> 300 000 in those published in the last 8 years) have been carried out. These studies generally include a fairly rigorous defi nition of asthma and have the additional benefi t of being able to establish the direction of the association.
Most prospective studies show that obesity is a risk factor for the de novo diagnosis of asthma, with the risk increasing between 1.1-fold and 3-fold [9-11]. In the prospective study with the highest number of subjects enrolled and with the longest follow-up (135 000 Norwegian men and women who were followed for 21 years) [11], the incidence of asthma increased 10% and 7% per unit increase in BMI in men and women, respectively. In general, prospective studies fi nd a positive association between baseline BMI and the subsequent development of asthma, thus suggesting that excess weight could favor the development of asthma. However, no unanimity exists regarding results: a recent cohort study [12] including 591 adults who were monitored for 20 years found an association between asthma and obesity, but multivariate analysis revealed that asthma was a risk factor for obesity and not the other way round.
Most of these studies show that the incidence of asthma and increased BMI are frequently related. In general, the more BMI increases, the more the incidence of asthma rises, and this effect is generally stronger among women than among men. However, this difference is always very small and seems to be related to the degree of adiposity in women. One study [13] carried out in a cohort of 1000 individuals found a signifi cant association between the percentage of body fat and asthma in women but not in men. However, bronchial infl ammation, as measured by exhaled nitric oxide, was not associated with body fat in either women or men. The study concluded that adiposity was associated with asthma and airway obstruction in women and that this does not appear to be due to infl ammation of the airways.
Studies in the Pediatric Population
Studies carried out in the pediatric population are much more heterogeneous both in terms of the strength of their results and in the direction of the asthma-obesity relationship. One study [14] of 9828 children aged between 6 and 14 years who were followed for 5 years showed that obesity increased the risk of suffering from asthma, a trend that was particularly pronounced in girls (those in the top quintile of adiposity had a 2.2-times greater risk of incident asthma in subsequent years). However, another study [15] carried out at practically the same time with the participation of 3792 children found that overweight and obesity increased the risk of bronchial asthma, more so in boys than in girls. A Finnish study [16] , which included 4719 participants born in 1996, showed that obesity at age 14 increased the risk of suffering from asthma in adulthood (31 years of age). Those participants who were obese both at 14 and 31 years of age were twice as likely to be asthmatics in adult life as those who were not obese at either of these ages. However, some studies do not show a signifi cant association between obesity and asthma [17].
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The most recent prospective study [18] carried out in children included 4393 children with no symptoms of asthma during the fi rst 2 years of their lives. These children were followed for 14 years and the study found that the group with elevated BMIs (above the 85 th percentile) at the time of recruitment had a 2.4-times greater risk for subsequent development of asthma than those children who had low BMIs. These data indicate that obesity is a risk factor for the appearance of asthma in early infancy, which is when a large number of patients develop the disease.
Pediatric studies, however, do not show a consistent relationship between obesity and atopy. In the children participating in the National Health and Nutrition Examination Study III (NHANES III) [19] , a signifi cant relationship was only found between BMI and asthma, but not with atopy, defi ned as the presence of atopic disease and positive skin tests.
Far fewer studies have attempted to link BMI and different features of asthma: analysis of the data from the cohort study Childhood Asthma Management Program (CAMP) [20] shows no relationship between BMI and different indicators of the control of asthma such as absenteeism from school, visits to emergency departments, need for systemic corticosteroids, need for hospitalization, eosinophilia, and levels of immunoglobulin (Ig) E. However, a weak correlation was found with coughing and exercise-induced wheezing. In any case, the low power of these results makes generalization diffi cult.
Studies Including Weight Change
Results from several studies suggest that just as weight gain increases the risk of asthma, so weight loss improves its outcome. The Nurse Health Study [9] concluded that, for people who gained more than 25 kg from 18 years of age, the relative risk of asthma increased by 4.7 in comparison with those whose weight remained stable.
In contrast, several studies show that weight loss improves asthma, at least in adults. Weight loss resulting from surgery produced improvements in the severity of asthma, drug use, and hospitalization [21] . Similarly, weight loss achieved by dieting is capable of increasing lung function in obese asthmatic patients: a loss of 15% of body weight led to better results in peak expiratory volume tests such as forced expiratory volume in the fi rst second of expiration (FEV 1 ) and forced vital capacity (FVC), lower symptom scores, and less frequent use of medication [22] .
Hypotheses That Justify the Association
Obesity and Lung Physiology
Obesity can lead to a reduction in pulmonary compliance, lung volumes, and the diameter of peripheral airways, and it can affect the volume of blood in the lungs and the ventilationperfusion relationship Pulmonary compliance is reduced for several reasons in obese subjects, including fat compression and infi ltration of the thorax or the increase in lung blood volumes. All of these factors produce a subjective increase in dyspnea [23] . Furthermore, obesity can also lead to limitations in airfl ow, with reduction in both FEV 1 and FVC. However, this reduction is typically symmetrical, with the FEV 1 /FVC ratio remaining unchanged. Some authors have even found a restrictive model in obese subjects with an increased FEV 1 /FVC ratio [24] . Such changes in lung physiology lead to superfi cial respiration in obese patients, with a reduction in lung volumes, especially expiratory reserve volume. This reduction in lung volumes is associated with a reduction in the diameter of peripheral airways that can lead to changes in the function of bronchial smooth muscle. This in turn leads to a change in the actinmyosin cross-bridge cycle, which can potentially increase both obstruction and bronchial hyperreactivity (BHR) [25] .
Obesity and Infl ammatory Mediators
The increase in the normal functioning of adipose tissue in obese subjects leads to a systemic proinfl ammatory state. In obese patients, serum concentrations of numerous cytokines, and soluble fractions of their receptors and chemokines have all been found to be increased [26] . Many of these mediators are synthesized and secreted by cells from adipose tissue and have been given the generic name of adipokines. This group includes IL-6, IL-10, eotaxin, tumor necrosis factor (TNF)-α, TGF-ß1, C-reactive protein, leptin, and adiponectin.
TNF-α has been shown to be present in adipocytes and is directly related to body fat. Furthermore, TNF-α is known to be elevated in asthma and is linked to the production of T H 2 cytokines (IL-4, IL-6) in bronchial epithelium, as a result of which higher TNF-α levels would lead to higher levels of these cytokines.
Serum levels of IL-6 are elevated in obese subjects and such levels have been associated with the severity of asthma [27] . Reductions in BHR have been found in obese mice treated with anti-IL-6, although not in normal-weight mice receiving the same treatment [28] .
Many recently published articles dealing with the relationship between asthma and obesity have focused on the role of leptin. Leptin is a hormone that is largely produced by adipocytes, although it is also expressed in the hypothalamus, the ovaries, and the placenta, and is found to be elevated in obese patients. It is believed that leptin acts as a lypostate-when the amount of fat stored in the adipocytes increases, leptin is released into the bloodstream. This constitutes a negative feedback signal for the hypothalamus, which responds by releasing anorexigenic peptides and suppressing the production of orexigenic peptides. Energy expenditure thus increases, as does the baseline metabolic rate and body temperature. At the same time, the point of hormonal balance for the reduction of lipogenesis and increase in lipolysis in adipose tissue is modifi ed.
Leptin seems to play a fundamental role in infl ammation in obese subjects: it possesses considerable structural homology with long-chain cytokines such as IL-6, and is capable of regulating the proliferation and activation of T cells, promoting angiogenesis, and recruiting activated monocytes and macrophages [29] . Furthermore, leptin is important for the normal development of the lung, as it is a critical mediator in the differentiation between lipofi broblasts and fi broblasts, and in the synthesis of lung surfactant [30] . In animal models, it has been shown that the exogenous administration of leptin increases lung infl ammation produced by exposure to ozone [31] , alters serum IgE titers, and increases BHR caused by allergens [32] . In humans, it has been suggested that leptin levels could be used to predict the development of asthma in children [33] . In a population of 5876 women, those with asthma were found to have higher levels than those who did not [34] . This study also found that the relationship between BMI and asthma did not change with serum leptin levels, thus suggesting that this protein may be considered a predictive, although independent, factor for asthma.
Unlike other adipokines, serum levels of adiponectin are reduced in obese subjects [35] . It has been shown that this hormone possesses anti-infl ammatory properties, even in the airways [36] , with the result that the lower levels in asthmatic subjects could play a role in the obesity-asthma relationship.
A systematic increase in eotaxin has also been found in obese individuals. Part of this chemokine is synthesized in adipocytes, and this suggests a potential role in the increased risk of asthma in obese patients [37] .
Genetic Factors
It is well known that, as a result of genetic pleomorphism, genes may exert several different effects. Thus, it is biologically possible to suggest that certain genes that are linked to one particular illness may also be linked to another. Specifi c regions of the human genome are linked to both asthma and obesity, for example, chromosomes 5q, 6, 11q13, and 12q [38] .
Chromosome 5q contains the genes ADRB2 and NR3C1. The ADRB2 gene, which codes for the ß 2 -adrenergic receptor exerts an infl uence on the sympathetic nervous system and is important for the control of tone in the airways and also for baseline metabolism. It has been postulated that the glucocorticoid receptor gene NR3C1 has been involved in the inflammatory responses associated with obesity and asthma [38] Chromosome 6 contains the genes of the main histocompatability complex and of TNF-α, which affect immune and anti-infl ammatory responses in both asthma and obesity (see above). Chromosome 11q13 contains the genes for the uncoupling proteins UCP2-UCP3 and for the receptor of low-affinity IgE. The UCP2-UCP3 proteins influence baseline metabolism but not asthma. In contrast, the receptor of low-affi nity IgE forms part of the infl ammatory response of T H 2 cells, whose levels increase in asthma, but not in obesity. Chromosome 12q contains the genes for infl ammatory cytokines linked both with asthma (IFN-γ, LTA4H, nitric oxide synthase-1) and with obesity (STAT6, type 1 insulinoid growth factor, CD36L1).
In addition, the ß 3 -adrenergic receptor, located primarily in adipose tissue, is involved in the regulation of lipolysis and thermogenesis, and morbidly obese patients with a genetic mutation in the gene for the ß 3 -adrenergic receptor have an increased capacity to gain weight [39] . Polymorphisms in the ß 2 -adrenergic receptor, which is located in chromosome 5q31-q32, have been associated with different asthma phenotypes, different levels of severity, and a response to ß-agonists [40] .
The change of Gln27 for Glu in this receptor has also been associated with obesity [41] 
Hormonal Factors
Ever since the fi rst longitudinal studies were carried out, there has been evidence of a greater effect of obesity on asthma in women than in men [9] . We know that the enzyme aromatase, which is responsible for converting androgens into estrogens, is present in adipose tissue. In obesity, the production of estrogens is generally increased and this is associated with early menarche in women and delay in the onset of puberty in men [42, 43] .
In the Tucson cohort, Castro-Rodríguez et al [44] found that the prevalence of asthma was greater in those obese girls who had early menarche (before 11 years of age) than amongst those who underwent menarche at a later age. This would seem to suggest that obesity disrupts the production (or peripheral sensitivity) of the hormones related to puberty in girls and that an increased production of female hormones (or sensitivity to them) disrupts lung development and the regulation of airway tone in pubertal girls.
The Infl uence of Diet
Several diet-related factors have been reported to infl uence the prevalence of asthma in adults and children. For example, the antioxidants (vitamins C and E), carotene, riboflavin, and pyridoxin can all exert an important effect by increasing immune function, reducing the symptoms of asthma/eczema, and improving lung function. Recently, Romieu et al [45] have reported that adult women who consumed fruit and vegetables (tomatoes, carrots, and leafy vegetables) had a lower prevalence of asthma. Higher consumption of trans fatty acids in a pediatric population has also been linked to a reduction in the prevalence of asthma [46] . However, it is important to highlight that the studies on diet and asthma were carried out in patients already diagnosed with asthma.
It is not known whether maternal diet during gestation can infl uence the development of obesity in children, but it is interesting to point out that the relationship between weight at birth (regardless of gestational age) and the risk of asthma follows a U-shaped curve, that is, both low and high weights at birth increase the risk of asthma [47, 48] . Similarly, the same U-shaped curve is seen in the relationship in males between low and high BMIs and greater BHR [49] . This suggests that "fetal programming" may have repercussions on the subsequent development of obesity and asthma.
Implications for Treatment
Data published in recent years indicate that obesity may affect the response of asthmatic patients to their normal treatment. Peters-Golden et al [50] analyzed patient response in relation to BMI in 3000 asthmatic patients given 1 of the following 3 treatments: placebo, inhaled corticosteroids (beclomethasone), and leukotriene receptor antagonists (montelukast). Whilst in the patients receiving beclomethasone there were no changes in drug effi cacy as related to patient weight, in the patients receiving placebo the number of days J Delgado, et al during which asthma was under control (days with less than 2 puffs of ß 2 antagonists, and no nocturnal awakenings or asthma attacks) was greater in normal-weight patients than in overweight or obese patients, even after adjustment for asthma severity. FEV 1 values also improved after the administration of placebo in lean, but not in obese, subjects. Given that the response to placebo is, probably, the result of more contact with health care personnel, improvement in breathing techniques, and greater avoidance of asthma triggers, these results may indicate that asthma in obese patients is less sensitive to this type of intervention.
However, in those patients with high BMIs who received montelukast, the clinical benefi t was greater than in lean patients, which suggests that leukotrienes play a more important role as mediators of symptoms in obese patients.
Another double-blind study [51] compared the effi cacy of placebo, montelukast, and theophyllines in asthmatics in relation to patient weight: in the patients treated with theophyllines, the relative risk of worsening symptoms was greater in obese asthmatics than in lean individuals.
Taken together, these results suggest that BMI is one of the variables that should be taken into consideration in asthmatic patients.
Conclusions
Most of the epidemiological data indicate that obesity can increase the prevalence and incidence of asthma, although this effect appears to be modest and depends on factors such as age and sex. It is clear that the treatment of obese asthmatics must include a weight control program, and it must be borne in mind that obesity may disrupt the response to normal antiasthmatic treatments.
The complex interrelation between obesity and asthma is an example of the interaction between genes and the environment in the pathogenesis of both disorders and it is very likely that more than 1 biological mechanism is involved. Obesity, by means of infl ammatory mechanisms or changes in lifestyle, can trigger asthmatic symptoms in susceptible individuals. The combination of diet and genes may alter the normal patterns of body growth (giving rise to obesity), the tone of the airways (giving rise to asthma), or both. Clearly, more research is needed to further elucidate these 2 phenomena and the multiple interrelationships that exist between them.
